Evidence map›Paper›PMID 24019515›Full record

ArticleThe Journal of biological chemistry2013

General control nonderepressible 2 (GCN2) kinase protects oligodendrocytes and white matter during branched-chain amino acid deficiency in mice.

Pengxiang She, Piyawan Bunpo, Judy K Cundiff, Ronald C Wek, Robert A Harris, Tracy G Anthony

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. A metabolic basis for motor deficits in mice lacking BCKDK.The Journal of nutritional biochemistry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. GATOR2 complex-mediated amino acid signaling regulates brain myelination.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Review
  9. GCN2 is essential for CD8Cancer immunology, immunotherapy : CII · 2020
    Article
  10. Review
  11. Nutrient Sensing and Redox Balance: GCN2 as a New Integrator in Aging.Oxidative medicine and cellular longevity · 2019
    Review
  12. Review
  13. Article
  14. Homeostatic responses to amino acid insufficiency.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pengxiang SheFrom the Department of Nutritional Sciences, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901.
Piyawan Bunpo
Judy K Cundiff
Ronald C Wek
Robert A Harris
Tracy G Anthony
Indiana University – Purdue University Indianapolis · USRutgers, The State University of New Jersey · US

Funding

Metabolic stress responses andeIF2 kinase GCN2R01GM049164 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI WEK, RONALD C · 1998 to 2019
$6.3M
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.R01HD070487 · NICHD · RUTGERS, THE STATE UNIV OF N.J. · PI ANTHONY, TRACY G. · 2011 to 2015
$1.9M
HISRS-DOMAIN AND REGULATING GCN2 PROTEIN KINASER29GM049164 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI WEK, RONALD C · 1993 to 1997
–
NICHD NIH HHS HD070487NICHD NIH HHS R01 HD070487NIGMS NIH HHS GM049164NIGMS NIH HHS R01 GM049164
6 · The paper itself

Abstract

Branched-chain amino acid (BCAA) catabolism is regulated by branched-chain α-keto acid dehydrogenase, an enzyme complex that is inhibited when phosphorylated by its kinase (BDK). Loss of BDK function in mice and humans causes BCAA deficiency and epilepsy with autistic features. In response to amino acid deficiency, phosphorylation of eukaryotic initiation factor 2α (eIF2∼P) by general control nonderepressible 2 (GCN2) activates the amino acid stress response. We hypothesized that GCN2 functions to protect the brain during chronic BCAA deficiency. To test this idea, we generated mice lacking both Gcn2 and Bdk (GBDK) and examined the development of progeny. GBDK mice appeared normal at birth, but they soon stopped growing, developed severe ataxia, tremor, and anorexia, and died by postnatal day 15. BCAA levels in brain were diminished in both Bdk(-/-) and GBDK pups. Brains from Bdk(-/-) pups exhibited robust eIF2∼P and amino acid stress response induction, whereas these responses were absent in GBDK mouse brains. Instead, myelin deficiency and diminished expression of myelin basic protein were noted in GBDK brains. Genetic markers of oligodendrocytes and astrocytes were also reduced in GBDK brains in association with apoptotic cell death in white matter regions of the brain. GBDK brains further demonstrated reduced Sod2 and Cat mRNA and increased Tnfα mRNA expression. The data are consistent with the idea that loss of GCN2 during BCAA deficiency compromises glial cell defenses to oxidative and inflammatory stress. We conclude that GCN2 protects the brain from developing a lethal leukodystrophy in response to amino acid deficiencies.

Indexed as

AnimalsCatalaseCerebral CortexEukaryotic Initiation Factor-2FemaleGene Expression RegulationHumansLeukoencephalopathiesMaleMaple Syrup Urine DiseaseMiceMice, KnockoutMyelin Basic ProteinOligodendrogliaOxidative StressProtein Kinases(3-methyl-2-oxobutanoate dehydrogenase (lipoamide)) kinaseCatalaseEif2ak4 protein, mouseEukaryotic Initiation Factor-2Myelin Basic ProteinProtein KinasesProtein Serine-Threonine KinasesSuperoxide DismutaseSuperoxide Dismutase 2Tumor Necrosis Factor-alphaAmino AcidBrainEndoplasmic Reticulum StressEpilepsyGene Knock-outGliaLeukodystrophyMyelinTranslation Initiation Factors

Identifiers

PMID24019515
PMCPMC3829435
OpenAlexW2063385165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.